Biotechnology and Government Funding

Michael Lawlor

Challenge, 2003, vol. 46, issue 1, 15-37

Abstract: Why is the United States the leader in biotechnology? The author argues it is because it has adopted a public-goods model actively involving government spending and decision-making. The private market alone will not support adequate basic research. But does the government support its research well? The author argues that it is not perfect, but it has been highly successful.

Date: 2003
References: Add references at CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
http://hdl.handle.net/10.1080/05775132.2003.11034184 (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:mes:challe:v:46:y:2003:i:1:p:15-37

Ordering information: This journal article can be ordered from
http://www.tandfonline.com/pricing/journal/MCHA20

DOI: 10.1080/05775132.2003.11034184

Access Statistics for this article

More articles in Challenge from Taylor & Francis Journals
Bibliographic data for series maintained by Chris Longhurst ().